Literature DB >> 22565108

Treatment of multidrug-resistant tuberculosis in a remote, conflict-affected area of the Democratic Republic of Congo.

L Shanks1, E W Masumbuko, N M Ngoy, M Maneno, S Bartlett, S S Thi, T Shah.   

Abstract

The Democratic Republic of Congo is a high-burden country for multidrug-resistant tuberculosis. Médecins Sans Frontières has supported the Ministry of Health in the conflict-affected region of Shabunda since 1997. In 2006, three patients were diagnosed with drug-resistant TB (DR-TB) and had no options for further treatment. An innovative model was developed to treat these patients despite the remote setting. Key innovations were the devolving of responsibility for treatment to non-TB clinicians remotely supported by a TB specialist, use of simplified monitoring protocols, and a strong focus on addressing stigma to support adherence. Treatment was successfully completed after a median of 24 months. This pilot programme demonstrates that successful treatment for DR-TB is possible on a small scale in remote settings.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22565108     DOI： 10.5588/ijtld.11.0240

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


  7 in total

1.  The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs.

Authors:  N S Shah; J Westenhouse; P Lowenthal; G Schecter; L True; S Mase; P M Barry; J Flood
Journal:  Public Health Action       Date:  2018-03-21

2.  Tuberculosis-related technical enquiries received by a national level institution in Japan, 2014-2016.

Authors:  M Urakawa; A Yasukawa; Y Hoshino; T Shimamura; S Hirao; Y Nagata; M Ota
Journal:  Public Health Action       Date:  2018-09-21

3.  Treating drug-resistant tuberculosis in a low-intensity chronic conflict setting in India.

Authors:  Edward Armstrong; Mrinalini Das; Homa Mansoor; Ramesh B Babu; Petros Isaakidis
Journal:  Confl Health       Date:  2014-12-01       Impact factor: 2.723

4.  Teleconsultation and Clinical Decision Making: a Systematic Review.

Authors:  Kolsoum Deldar; Kambiz Bahaadinbeigy; Seyed Mahmood Tara
Journal:  Acta Inform Med       Date:  2016-07-16

Review 5.  [Control and management strategies in multidrug-resistant tuberculosis: literature reviewEstrategias de control y atención de la tuberculosis multirresistente: una revisión de la literatura].

Authors:  Jaqueline Garcia de Almeida Ballestero; Mônica Cristina Ribeiro Alexandre D Auria de Lima; Juliana Masini Garcia; Roxana Isabel Cardozo Gonzales; Amélia Nunes Sicsú; Fernando Mitano; Pedro Fredemir Palha
Journal:  Rev Panam Salud Publica       Date:  2019-02-06

6.  Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.

Authors:  André N H Bulabula; Jenna A Nelson; Eric M Musafiri; Rhoderick Machekano; Nadia A Sam-Agudu; Andreas H Diacon; Maunank Shah; Jacob Creswell; Grant Theron; Robin M Warren; Karen R Jacobson; Jean-Paul Chirambiza; Dieudonné Kalumuna; Bertin C Bisimwa; Patrick D M C Katoto; Michel K Kaswa; Freddy M Birembano; Liliane Kitete; Martin P Grobusch; Zacharie M Kashongwe; Jean B Nachega
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

7.  Patients and Medical Staff Attitudes Toward the Future Inclusion of eHealth in Tuberculosis Management: Perspectives From Six Countries Evaluated using a Qualitative Framework.

Authors:  Ioana Margineanu; Christina Louka; Maria Vincenti-Gonzalez; Antonia Morita Iswari Saktiawati; Johannes Schierle; Kabiru Mohammed Abass; Onno Akkerman; Jan-Willem Alffenaar; Adelita V Ranchor; Ymkje Stienstra
Journal:  JMIR Mhealth Uhealth       Date:  2020-11-02       Impact factor: 4.773
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.